Mohammad Reza Shiee1, Eshrat Beigom Kia2, Farzaneh Zahabiun1, Mahmood Naderi3, Elahe Motevaseli4, Shahram Nekoeian4, Majid Fasihi Harandi5, Ahmad Reza Dehpour6,7. 1. Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. 2. Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. keiaeshr@tums.ac.ir. 3. Cell-Based Therapies Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran. 4. Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. 5. Research Center for Hydatid Disease in Iran, Kerman University of Medical Sciences, Kerman, Iran. 6. Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran. Dehpoura@tums.ac.ir. 7. Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Dehpoura@tums.ac.ir.
Abstract
BACKGROUND: Cystic echinococcosis (CE) is a disease caused by the larval stage of Echinococcus granulosus sensu lato (s.l.). The treatment of CE mainly relies on the use of benzimidazoles, which can commonly cause adverse side effects. Therefore, more efficient treatment options are needed. Drug repurposing is a useful approach for advancing drug development. We have evaluated the in vitro protoscolicidal effects of tropisetron and granisetron in E. granulosus sensu stricto (s.s.) and assessed the expression of the calcineurin (CaN) and calmodulin (CaM) genes, both of which have been linked to cellular signaling activities and thus are potentially promising targets for the development of drugs. METHODS: Protoscoleces (PSC) of E. granulosus (s.s.) (genotype G1) obtained from sheep hepatic hydatid cysts were exposed to tropisetron and granisetron at concentrations of 50, 150 and 250 µM for various periods of time up to 10 days. Cyclosporine A (CsA) and albendazole sulfoxide were used for comparison. Changes in the morphology of PSC were investigated by light microscopy and scanning electron microscopy. Gene expression was assessed using real-time PCR at the mRNA level for E. granulosus calcineurin subunit A (Eg-CaN-A), calcineurin subunit B (Eg-CaN-B) and calmodulin (Eg-CaM) after a 24-h exposure at 50 and 250 µM, respectively. RESULTS: At 150 and 250 µM, tropisetron had the highest protoscolicidal effect, whereas CsA was most effective at 50 µM. Granisetron, however, was less effective than tropisetron at all three concentrations. Examination of morphological alterations revealed that the rate at which PSC were killed increased with increasing rate of PSC evagination, as observed in PSC exposed to tropisetron. Gene expression analysis revealed that tropisetron at 50 μM significantly upregulated Eg-CaN-B and Eg-CaM expression while at 250 μM it significantly downregulated both Eg-CaN-B and Eg-CaM expressions; in comparison, granisetron decreased the expression of all three genes at both concentrations. CONCLUSIONS: Tropisetron exhibited a higher efficacy than granisetron against E. granulosus (s.s.) PSC, which is probably due to the different mechanisms of action of the two drugs. The concentration-dependent effect of tropisetron on calcineurin gene expression might reflect its dual functions, which should stimulate future research into its mechanism of action and evaluation of its potential therapeutical effect in the treatment of CE.
BACKGROUND:Cystic echinococcosis (CE) is a disease caused by the larval stage of Echinococcus granulosus sensu lato (s.l.). The treatment of CE mainly relies on the use of benzimidazoles, which can commonly cause adverse side effects. Therefore, more efficient treatment options are needed. Drug repurposing is a useful approach for advancing drug development. We have evaluated the in vitro protoscolicidal effects of tropisetron and granisetron in E. granulosus sensu stricto (s.s.) and assessed the expression of the calcineurin (CaN) and calmodulin (CaM) genes, both of which have been linked to cellular signaling activities and thus are potentially promising targets for the development of drugs. METHODS: Protoscoleces (PSC) of E. granulosus (s.s.) (genotype G1) obtained from sheephepatic hydatid cysts were exposed to tropisetron and granisetron at concentrations of 50, 150 and 250 µM for various periods of time up to 10 days. Cyclosporine A (CsA) and albendazole sulfoxide were used for comparison. Changes in the morphology of PSC were investigated by light microscopy and scanning electron microscopy. Gene expression was assessed using real-time PCR at the mRNA level for E. granulosus calcineurin subunit A (Eg-CaN-A), calcineurin subunit B (Eg-CaN-B) and calmodulin (Eg-CaM) after a 24-h exposure at 50 and 250 µM, respectively. RESULTS: At 150 and 250 µM, tropisetron had the highest protoscolicidal effect, whereas CsA was most effective at 50 µM. Granisetron, however, was less effective than tropisetron at all three concentrations. Examination of morphological alterations revealed that the rate at which PSC were killed increased with increasing rate of PSC evagination, as observed in PSC exposed to tropisetron. Gene expression analysis revealed that tropisetron at 50 μM significantly upregulated Eg-CaN-B and Eg-CaM expression while at 250 μM it significantly downregulated both Eg-CaN-B and Eg-CaM expressions; in comparison, granisetron decreased the expression of all three genes at both concentrations. CONCLUSIONS:Tropisetron exhibited a higher efficacy than granisetron against E. granulosus (s.s.) PSC, which is probably due to the different mechanisms of action of the two drugs. The concentration-dependent effect of tropisetron on calcineurin gene expression might reflect its dual functions, which should stimulate future research into its mechanism of action and evaluation of its potential therapeutical effect in the treatment of CE.
Authors: Thomas Junghanss; Antonio Menezes da Silva; John Horton; Peter L Chiodini; Enrico Brunetti Journal: Am J Trop Med Hyg Date: 2008-09 Impact factor: 2.345
Authors: Laureano de la Vega; Eduardo Muñoz; Marco A Calzado; Klaus Lieb; Eduardo Candelario-Jalil; Harald Gschaidmeir; Lothar Färber; Wolfgang Mueller; Thomas Stratz; Bernd L Fiebich Journal: Biochem Pharmacol Date: 2005-08-01 Impact factor: 5.858
Authors: Reza Rahimian; Ahmad Reza Dehpour; Gohar Fakhfouri; Mohammad Reza Khorramizadeh; Jean-Eric Ghia; Mohammad Seyedabadi; Antonio Caldarelli; Kazem Mousavizadeh; Mehdi Forouzandeh; Shahram Ejtemaei Mehr Journal: Brain Res Date: 2011-08-27 Impact factor: 3.252
Authors: Sajad Hussain Arif; Nazir Ahmad Wani; Showkat Ahmad Zargar; Mehmood Ahmad Wani; Rehana Tabassum; Zahoor Hussain; Ajaz Ahmad Baba; Riyaz Ahmad Lone Journal: Int J Surg Date: 2008-08-16 Impact factor: 6.071
Authors: Gordana Panic; Urs Duthaler; Benjamin Speich; Jennifer Keiser Journal: Int J Parasitol Drugs Drug Resist Date: 2014-07-30 Impact factor: 4.077